Activity Title
Start Activity
Optimizing Success in Positive Airway Pressure (PAP) Therapy for Obstructive Sleep Apnea: The Role of the MaskStatement of Need/Program Overview
In this educational activity, we will review the importance of the CPAP interface in achieving success in obstructive sleep apnea treatment. We will discuss the evolution of mask technology and mask fitting approaches, including virtual apps. Side effects and outcomes will be compared between nasal and oronasal masks. Evaluation of nasal symptoms, indications for clinical and surgical treatment for nasal obstruction and outcomes of nasal surgency on CPAP use will be discussed. The excessive use of oronasal masks and rationale for choosing nasal masks as first-line options for CPAP treatment will be presented. The mechanisms involved in the better outcomes of nasal masks and of potential ineffectiveness of oronasal CPAP treatment will be reviewed. Detection and management strategies of excessive mouth leak during nasal CPAP will be proposed.
Target Audience
This activity is intended for healthcare professionals involved in the management of obstructive sleep apnea that include Pulmonologists, Pneumologists, Respirologists, Respiratory Physiotherapists, Respiratory Therapists (Hospital, Home), Neurologists, Pediatricians, Otorhinolaryngologists, Sleep Technicians, Home Healthcare Providers, Critical Care Medicine Specialists, Internal Medicine Specialists, Primary Care Physicians (General and Family Practitioners), Advanced Practice Nurses, Nurse Practitioners, Physicians Assistants, Managed Care Medical Directors, and other Practitioners and Payers.
Educational Objectives
After completing this activity, the participant should be better able to:
1. Discuss the evolution of mask technology and fitting.
2. Compare side effects of nasal and oronasal masks for CPAP treatment.
3. Define importance of a patent nasal airway.
4. Analyze clinical and surgical intervention outcomes on PAP acceptance & adherence.
5. Summarize potential ineffectiveness of oronasal CPAP for OSA patients.
6. Describe longitudinal treatment of OSA with nasal CPAP as first line option, including management of excessive oral leak.Faculty
Pedro Genta, MD
Associate Professor of Medicine
Division of Pulmonary Medicine
University of São PauloJennifer Newitt, MD
Assistant Professor of Medicine
University of PittsburghOlivier M. Vanderveken, MD, PhD
Full Professor in Otorhinolaryngology, Head and Neck Surgery & Sleep Surgery
Translational Neurosciences
Vice-Dean
Faculty of Medicine and Health Sciences
University of Antwerp
Head of Department and Chair
Department of ENT, Head and Neck Surgery
Antwerp University Hospital
Antwerp, BELGIUMProgram Agenda
Section 1: Overview of PAP masks, approach to fit and impact on PAP therapy adherence (38.5 minutes)
Section 2: Patient Interface: PAP Therapy for Obstructive Sleep Apnea (28.75 minutes)
Section 3: Nasal Masks as first line options for CPAP (39 minutes)European Accreditation Council for Continuing Medical Education (EACCME)
EACCME Accreditation Statement
The Optimizing Success in Positive Airway Pressure (PAP) Therapy for Obstructive Sleep Apnea: The Role of the Mask, made available and organized by Dane Garvin Ltd., is accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) to provide the following CME activity for medical specialists. Only those e-learning materials that are displayed on the UEMS-EACCME® website have formally been accredited.
EACCME Term Offering
November 7, 2025 to November 7, 2027
Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM . Information on the process to convert EACCME® credit to AMA credit can be found at https://edhub.ama-assn.org/pages/applications.
Information regarding the conversion of EACCME® credits
Credit will be converted based on one (1) hour of participation equalling one credit for all activities. Physicians wishing to convert EACCME® credits to AMA PRA Category 1 Credit™ will be required to access the AMA website at https://edhub.ama-assn.org/pages/applications to obtain the necessary paperwork and instructions. Physicians and other health care professionals will be required to pay a processing fee to the AMA.For other countries, please contact the relevant national/regional accreditation authority.
American Association for Respiratory Care (AARC) Accreditation

AARC Designation Statement
This Non-traditional program has been approved for 1.75 contact hour Continuing Respiratory Care Education (CRCE) credit by the American Association for Respiratory Care; 9425 N. MacArthur Boulevard, Suite 100, Irving TX 75063Term Offering - AARC / CRCE
This activity was released on August 25, 2025 and is valid for two years. Requests for credit must be made no later than August 25, 2027.
The above term offering is for the following accreditation: AARC.
Other Allied Healthcare Professional
Participation Statement
Dane Garvin Ltd. has awarded 1.0 Participation Credit(s) for qualified attendees in the enduring activity Optimizing Success in Positive Airway Pressure (PAP) Therapy for Obstructive Sleep Apnea: The Role of the Mask.-
Educational Grant
This educational activity is independently produced and is financially supported with an unrestricted educational grant by Philips Respironics.
Copyright
Copyright© Dane Garvin Ltd. All Rights Reserved. Permission for use granted to accreditation providers.
Web interface provided by Dane Garvin Ltd.
